This HTML5 document contains 50 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n15http://linked.opendata.cz/resource/drugbank/drug/DB04074/identifier/kegg-compound/
n12http://linked.opendata.cz/resource/drugbank/drug/DB04074/identifier/pdb/
n17http://linked.opendata.cz/resource/mesh/concept/
n13http://linked.opendata.cz/resource/drugbank/drug/DB04074/identifier/pubchem-compound/
n10http://linked.opendata.cz/resource/drugbank/drug/DB04074/identifier/pubchem-substance/
n14http://linked.opendata.cz/resource/drugbank/drug/DB04074/identifier/drugbank/
n6http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n7http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n16http://linked.opendata.cz/ontology/mesh/
n3http://linked.opendata.cz/ontology/drugbank/
n11http://linked.opendata.cz/resource/drugbank/drug/DB04074/identifier/chebi/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB04074
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB04074 n7:DB04074
dcterms:title
Alpha-ketoisovalerate
adms:identifier
n10:46508074 n11:16530 n12:KIV n13:49 n14:DB04074 n15:C00141
n3:synonym
2-Oxoisovalerate 2-Oxoisopentanoate 3-Methyl-2-oxobutyric acid 2-Oxo-3-methylbutanoate 3-Methyl-2-oxobutanoic acid 2-Ketovaline 3-Methyl-2-oxobutanoate 2-Keto-3-methylbutyric acid alpha-Ketovaline
n16:hasConcept
n17:M0041732
n3:IUPAC-Name
n4:271B5EB1-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B5EB7-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5EB6-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5EB3-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5EB4-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5EB5-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B5EAF-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B5EB0-363D-11E5-9242-09173F13E4C5 n4:271B5EAD-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B5EAE-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5EBD-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5EBE-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B5EB8-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B5EB9-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B5EBB-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B5EBA-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B5EBC-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
759-05-7
n3:Bioavailability
n4:271B5EC3-363D-11E5-9242-09173F13E4C5
n3:Boiling-Point
n4:271B5EC8-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5EC5-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5EC6-363D-11E5-9242-09173F13E4C5
n3:Melting-Point
n4:271B5EC7-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5EC2-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5EC1-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5EC4-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5EB2-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B5EBF-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5EC0-363D-11E5-9242-09173F13E4C5